The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis

BACKGROUND: Until now, there is no effective anti-fibrotic therapy available for liver cirrhosis. Stem cell therapies have been studied for the treatment of hepatic fibrosis. However, the use of embryonic stem cells or induced pluripotent stem cells (iPSC) has limitations such as ethical concern or...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Stem Cell Res Ther
Hlavní autoři: Park, Suhyun, In Hwang, Seon, Kim, Jonghun, Hwang, Seoyeon, Kang, Sohee, Yang, Sera, Kim, Jonghwa, Kang, Wonseok, Kim, Kyun-Hwan, Han, Dong Wook, Paik, Yong-Han
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6330392/
https://ncbi.nlm.nih.gov/pubmed/30635054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-1127-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky